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Ox-LDL, Lysophospatidy Choline Platelet Activating Factor,
IL-6 Expression Level and Foam Cell Number with Darappabdib
Treatment in Early Development of Atherosclerosis: In Vivo Study
for Type 2 Diabetes Mellitus Model
TEUKU HERIANSYAH,1 BAMBANG BUDI SISWANTO,2 ANWAR SANTOSO,2 DJANGGAN SARGOWO,3
IMAM SUBEKTI,4 AULANI' AM,5 RENAN SUKMAWAN,2 NURJATI HAIRANI SIREGAR,6 SAPTAWATI
BORDOSONO,7 TITIN ANDRI WIHASTUTI8
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HERIANSYAH ET AL.: Ox-LDL, Lysophospatidy Choline Platelet Activating Factor, IL-6 Expression Level
and Foam Cell Number with Darappabdib Treatment in Early Development of Atherosclerosis: In Vivo Study for
Type 2 Diabetes Mellitus Model. Background: Insulin resistance in type 2 Diabetes Melitus (T2DM) is an extensive
tissue damage condition due to vascular inflammation and oxidative stress. Lp-PLA2 has an antiinflammatory role as
it hydrolyze atherogenesis mediators such as ox-LDL and platelet activating factor (PAF) and produces
lysophosphatidylcholine (LysoPC) and oxidized fatty acid that have pro-inflammatory, proliferative and pro-atherogenic
effect. Methods and results: This study aimed to discover the expression of ox-LDL level, LysoPC, PAF, IL-6 and
foam cell numbers in aorta of T2DM in vivo model with darapladib treatment. True experimental laboratory and only
post test with control group design using 30 Spraque Dowley rats that is divided into 3 main groups: normal, T2DM,
and T2DM with the darapladib administration group. Each group consisted of 2 serials treatment time:
8-weeks and 16-weeks treatment groups. Parameter measured was IL-6, oxidized LDL and PAF, LysoPC, IL-6, foam
cells and also blood glucose, lipid profile, and insulin plasma level. ANOVA test results showed that darapladib were
significantly (p=0.000) lowering ox-LDL level, LysoPC, PAF, IL-6 expression and foam cells number in the aorta on
T2DM in vivo model. Conclusions: This study concludes that dalapladib proved to have a role as anti atherogenesis
on T2DM model. (J HK Coll Cardiol 2016;24:64-73)
Atherosclerosis, Darapladib, Type 2 DM
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Introduction
Today, cardiovascular disease (CVD) remains as
a serious global health problem and has become the
leading cause of death in both developed and developing
countries. CVD incidence in Indonesia turned out to be
much higher than the other developed countries with
cases number is 150.8 compared to 80.5 in the United
States and 31.2 per 100,000 population in Japan. CVD
death rate in Indonesia reaches 243,048 or 17.05% of
total deaths. This condition puts CVD as the first cause
of death from 20 leading causes of death in Indonesia.1
Atherosclerosis is the most common cause of CVD,
including coronary heart disease (coronary artery
disease/CAD), cerebrovascular disease (stroke) and
peripheral blood vessel diseases (peripheral artery
disease /PAD).2
Type 2 Diabetes mellitus (T2DM) is one of major
classical risk factors for atherosclerosis. 3 Clinical
condition with insulin resistance and T2DM is a
condition of an extensive tissue damage due to vascular
inflammation and oxidative stress.4 Hyperglycemia that
occurred in DM type 2 increase Reactive Oxygen
Species (ROS) production.5 Enzymatic activity and
lipoprotein phospholipase A2 (Lp-PLA2) expression
have been studied as a biomarker of CVD risk in people
with CAD and healthy individual.6 The understanding
about Lp-PLA2 role in the cardiovascular disease
pathophysiology remains controversial and far from well
established. Lp-PLA2 antiinflammatory role is
demonstrated by this enzyme ability to hydrolyze
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mediators, such as ox-LDL and platelet activating
factor (PAF), that could potentially have a role in
atherogenesis. At the same time, hydrolysis products of
these molecules that are mediated by Lp-PLA2, such as
lysophosphatidylcholine (LysoPC) and oxidized fatty
acid, have pro-inflammatory, proliferative and proatherogenic effect.
In the last decade, a new pharmacological therapy
for atherosclerosis, which actively, selectively, and
reversibly inhibit Lp-PLA2 is being developed and the
result is darapladib. Darapladib is a substance that
hydrolyzes Lp-PLA2 substrate. Darapladib forms noncovalent bonds and reversibly with human recombinant
Lp-PLA2. Darapladib is lipophilic and has good
membrane permeability. Darapladib reduce caspase-3
and caspase-8 activity, also inhibits macrophage
apoptosis induced by ox-LDL.
Several studies stated that darapladib show
significant results in inhibiting atherosclerosis
process, 7 both in vitro and in vivo experiments. 8,9
Positive results are also shown in a trial study in
patients who undergoing carotid endarterectomy.10
However, there are several opinions regarding
darapladib function as atherosclerosis treatment,
because some clinical trials show negative results of
darapladib usage in reducing mortality from
cardiovascular disease, myocardial infarction, or
stroke.11 Based on that facts, the aim of this study is
to determine the expression ox-LDL levels, LysoPC,
PAF, IL-6 and foam cell number in aorta using in vivo
T2DM model with darapladib treatment.
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Materials and Methods
Study Group
This study used 4 weeks old male Sprague
Dawley Rats and weigh around 150-200 grams as animal
model. Samples were obtained from Bogor Agricultural
University, Bogor, Indonesia. Samples were divided into
three groups; normal group (N); type 2 DM model
groups (DM) which fed with High Fat Diet (HFD) and
given Streptozotocin (STZ) injection intraperitoneal low
dose 35 mg/kgBW, and type 2 DM model with
darapladib administration group (DMDP). Each group
was divided into two serial time, 8 weeks (early phase)
and 16 weeks (late phase). Darapladib was obtained from
Glaxo Smith Kline. Samples were given darapladib via
oral 20 mg/kgBW once per day with duration based on
time serial groups. In short, there were 6 groups in total.
N8 and N16 for normal groups (8 and 16 weeks), DM8
and DM16 for T2DM model groups (8 and 16 weeks),
and DMDP8 and DMDP16 for T2DM model with
darapladib administration groups (8 and 16 weeks).
Normal rats food contained 3.43 total energy
calories (kcal/g) (67% carbohydrate, 21% protein, and
12% fat), while HFD contained 5.29 total energy calorie
(kcal/g) (58% fat, 17% carbohydrate, and 25% protein).
Each kilogram of vitamins and minerals mixture
contained 2000000 IU Vitamin A, 400000 IU Vitamin
D3, 0.8 grams Vitamin B2, 300 units Vitamin E, 0.4
grams Vitamin K, 1 gram calcium pantothenate, 4 grams
Nicotinamide, 2.4 gram Vitamin B12, 60 grams Choline
Chloride, 300 grams Calcium, 2.75 grams Manganese,
0.1 grams Iodine, 3 grams Iron, 6 grams Zinc, 0.8 grams
Copper, and 0.18 grams Cobalt.12 30 grams food were
given for each rat everyday. Parameter measurement was
done at the Central Laboratory of Biological Sciences,
Brawijaya University, Brawijaya University, Malang,
Indonesia. Slicing and staining samples were done in
the Pathological Anatomy Laboratory, Faculty of
Medicine, University of Brawijaya, Malang, Indonesia

Blood Glucose Measurement
STZ 20 mg/kgBW was administered before the
first measurement of blood glucose to induce type 2
diabetes mellitus. Type 2 diabetes mellitus was diagnosed

J HK Coll Cardiol, Vol 24

after blood glucose level measurement using GlucoDR
blood glucose test meter (All Medicus Co. Ltd, Dongangu, Anyang-si, Korea). Type 2 diabetes mellitus
was diagnosed after obtaining blood glucose levels
>200 mg/dL in rats.

Lipid Profile Levels Measurement
Lipid profiles (total cholesterol, HDL (High
Density Lipoprotein), and LDL (Low Density
Lipoprotein)) were measured in rat blood serum using
EnzyChromTM kit.

Insulin Resistance Measurement
Insulin in rat's blood plasma were measured using
Rat INS (insulin) ELISA kit (Cat. No. E-EL-R2466).
The obtained results are still in ng/mL units. Plasma
insulin levels were converted into IU / L. WHO formula
were used by dividing the result with 0.0347, as 1 IU is
equivalent with 0.0347 mg/L.13 Insulin resistance can
be measured with HOMA-IR (homeostatic model
assessment-insulin resistance) formula especially in rats,
which required some data, such as fasting glucose and
plasma insulin levels by the following formula:14
HOMA-IR =

FBS x FINS
14,1

Explanation:
HOMA-IR : Homeostatic Model Assessment-Insulin
Resistance
FBG
: Fasting Blood Glucose (mmol/L)
FINS
: Fasting Insulin Plasma (µgU/mL)
Interpretation of HOMA-IR calculation in rats is
if the result >1,716 then it can be categorized as insulin
resistance with 83.87% sensitivity and 80.56%
specificity (95% confidence interval).15

IL6 Expression Measurement
IL-6 was measured using immunofluorescence.
Aortic tissues were previously fixed with PHEMO
buffer (68 mM PIPES, 25 mM, HEPES, pH 6.9,
15 mMEGTA, 3 mM MgCl2, 10% [v/v] dimethyl
sulfoxide containing 3.7% formaldehyde and 0.05%
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glutaraldehyde), then were processed by
imumunofluoresence double labeling with anti-rat
antibody Lp-PLA2 using rhodamin secondary antibody
and anti-rat antibody IL-6 using fluorescein
isothiocyanate (FITC) secondary antibody (BIOS Inc.,
Boston, MA, USA). These parameter was observed using
confocal laser scanning microscopy (Olympus
Corporation, Tokyo, Japan) and was quantitatively
analyzed using Olympus FluoViewsoftware (version
1.7A; Olympus Corporation).

Ox-LDL Measurement
Ox-LDL was measured using rats aorta tissue as
samples. The rats had been fasted a day before the sample
obtained. Ox-LDL level was measured by Sandwich
ELISA method using Rat Ox-LDL ELISA kit (Cat.
No. E-EL-R0710). The first step was antigen coating,
100 µgL standard and sample were put into well that are
coated with antibody before then incubated in 37oC for
90 minutes. Residual antigen that was not bound with
antibody were disposed. After that, add 100 µgL Biotinantibody into each well. Incubated each well in 37oC
for 1 hour. The fluid in well was aspirated and washed
by wash buffer for 3 times. Next, 100 µgL HRP avidin
was added into each well and incubated in 37oC for 30
minutes. Repeat the aspiration and washing process 5
times. Add 90 µgL TMB substrate into each well then
incubated in 37oC for 15 minutes in light-free area.
50 µgL stop reaction was added to stop the reaction.
After 5 minutes read by ELISA reader at a wavelength
of 450 nm.

LysoPC Measurement
The used samples were serum and rat's aorta
homogenates. The used tool was 6460 triplequadrupole
LCMS / MS System, Agilent Technologies, USA.
Standard LysoPC material (16:0) used was 1-palmitoyl2-Hydroxy-sn-Glycero-3-Phosphocholine (16:0), cat
85567P, lot 16LPC-79, Avanti Polar Lipids, Inc., 700
Industrial Park drive, Alabaster, Alabama 35007-9105,
USA. Standard LysoPC internal material (16: 0) used
was 1-palmitoyl (D31) -2-Hydroxy-sn-Glycero-3Phosphocholine (16: 0), paint 85567P, lot 16 LPC-79,
Avanti PolarLipids, Inc., 700 Industrial Park Drive,
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Alabaster, Alabama 35007-9105, USA. Standard LysoPC
material (18:0) used was 1-Stearoyl-2-Hydroxy-snGlycero-3-Phosphocholine(16:0), cat 85567P, lot
16LPC-79, Avanti Polar Lipids, Inc, 700 Industrial
Park Drive, Alabaster, Alabama 35007-9105, USA.
Standards calibration range used were 250-16000 ng/
mL. Dilution factors of aorta homogenates samples
16-7 for LysoPC Stearoyl was 2X. Serum sample
dilution factors was 20X, except palmitoyl (16:0)
Code 8-1 and 8-2 itwas 40X, and Stearoyl (18: 0) Code
8-1 was 80X. Standard material used specifically for
research (Research Use Only). LysoPC analysis
procedure refers to journals: Takatera A, et. al.
Blood Lysophosphatidylcholine (LPC) levels and
Characteristic Molecular Species in Neonates:
Prolonged Low Blood LPC Levels in Very Low Birth
Weight Infants. Pediatr Res:477-482, 2007.

PAF Measurement
PAF concentrations measurement in rat blood
plasma samples were conducted by competitive
ELISA method using Rat Platelet Activating Factor
ELISA kit (Cat. No. MBS722041). Competitive
ELISA begins with coating antigen. Standard and
100 µgL sample were inserted into well (to form using
PBS). Then, 50 µgL conjugate was added into each
well (except blank well) and incubated it in 37oC for
1 hour. Aspirated and washed with wash buffer
5 times. Add 50 µgL substrate A and 50 µgL substrate
B to each well and incubated for 10-15 minutes in
37oC (avoid light). 50 µgL stop solution was added
to stop reaction in each well. After 5 minutes read by
ELISA reader at a wavelength of 450 nm.

Foam Cells Measurement
Aortic tissues were prepared using a frozen
section technique and stained with hematoxylineeosin.
After aortic tissues preparation, foam cells were
measured using a microscope with 400 magnification
and dotSlide Olyvia version 2.4 software (Olympus
America Inc., Center Valley, PA, USA). Examination
and calculation of foam cells number were performed
for each 10 microscope fields after taking images of the
aortic tissues.
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Ethics
We obtained ethical approval for animal treatment
and experimental processes in this study from Animal
Care and Use Committee Brawijaya University Number
229-KEP-UB.

Statistical Analysis
One-way analysis of variance (ANOVA) test was
used to determine the effects of time series factor,
darapladib treatment, and the interaction between time
and darapladib treatment on mRNA Lp-PLA2 expresion,
ox-LDL, PAF, LysoPC, PAF and foam cells in Spraque
Dowley rats with type 2 diabetes mellitus. This analysis
was continued by post hoc test using Duncan method to
detect parameter differences in each treatment group.
SPSS software version 20 (IBM Corporation, New York,
NY, USA) was used for data analysis.

Results
Total cholesterol level range was observed from
56.560 to 123.002 (mg/dL). The highest total cholesterol
level was found in DM8 group (123.002 mg/dL).
Meanwhile, the lowest total cholesterol level was found
in N16 group (56.560 mg/dL). HDL level range was
observed from 4.958 to 35.767 (mg/dL). The highest
HDL level was found in N16 (35.767 mg/dL).
Meanwhile, the lowest HDL level was found in DM8
group (4.958 mg/dL). VLDL/LDL level range was
observed from 19.241 to 95.531 (mg/dL). The highest
VLDL/LDL level was found in DM8 group (95.531 mg/
dL). Meanwhile, the lowest VLDL/LDL level was found
in N16 group (19.241 mg/dL). Fasting glucose level
range was observed from 79.6 to 147.8 (mg/mL). The
highest fasting glucose level was found in DM16 group
(147.8 mg/mL). Meanwhile, the lowest fasting glucose
level was found in N16 (79.6 mg/mL). Plasma insulin
level range was observed from 4.664 to 40.220 (ng/mL).
The highest plasma insulin levels was found in DM16
(40.220 ng/mL). Meanwhile, the lowest plasma insulin
levels was found in N8 group (4.664 ng/mL). HOMAIR value range was observed from 0.462 to 3.789. The
highest HOMA-IR value was found in DM16 (3.789).
Meanwhile, the lowest HOMA-IR value was found in

J HK Coll Cardiol, Vol 24

N16 group (0.462).
Ox-LDL level range was observed from 1.347 to
34.049 (ng/mL). The highest ox-LDL level was found
in DM16 group (34.049 ng/mL). Meanwhile, the lowest
ox-LDL level was found in N8 group (1.347 ng/mL).
ANOVA test showed that ox-LDL level was significantly
(p<0.050) influenced by time series, darapladib
treatment, and also an interaction between time series
and darabladib treatment (Figure 1A).
LysoPC level range was observed from 28.427 to
266.677 (ng/g aorta). The highest LysoPC level was
found in N8 group (266.677 ng/g aorta). Meanwhile,
the lowest LysoPC level was found in DMDP16 group
(28.427 ng/g aorta). ANOVA test showed that LysoPC
level was significantly (p<0.050) influenced by time
series, darapladib treatment, and also an interaction
between time series and darabladib treatment (Figure
1B).
PAF level range was observed from 0.726 to
1.963 (ng/mL). The highest PAF level was found in
DM16 group (1.963 ng/mL). Meanwhile, the lowest PAF
level was found in N8 group (0.726 ng/mL). ANOVA
test showed that PAF level was significantly (p<0.050)
influenced by time series, darapladib treatment, and also
an interaction between time series and darabladib
treatment (Figure 1 C).
IL-6 expression range was observed from
634.60552 to 792.131 (AU). The highest IL-6 expression
was found in DM16 group (792.131 AU). Meanwhile,
the lowest IL-6 expression was found in the DMDP8
group (634.60552 AU). ANOVA test showed that IL-6
expression was significantly (p<0.050) affected by
darapladib treatment factor. Meanwhile, time series
factor and interaction between time series and darapladib
did not significantly (p>0.050) influenced IL-6
expression (Figure 1D). Foam cells number range was
observed from 80 to 138.8 (cell). The highest foam cells
number was found in DM16 group (138.8 cells).
Meanwhile, the lowest foam cells number was found in
N8 group (80 cells). ANOVA test showed that foam cells
number was significantly (p<0.050) affected by
darapladib administration factor. Meanwhile, time series
factor and interaction between time series and darapladib
treatment did not significantly (p>0.050) influenced the
amount of foam cell (Figure 1E).
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Figure 1. The expression of ox-LDL level, LysoPC, PAF, IL-6 and foam cell numbers in aorta for each group,
(A) ox-LDL tissue, (B) LysoPC serum, (C) PAF, (D) IL-6, (E) Foam cell.
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Discussion
High-Fat Diet (HFD) can increase dyslipidaemia
and insulin resistance incidence that can cause a rise in
blood sugar.16 In DM model, Total Cholesterol (TC) and
Low-Density Lipoprotein (LDL) increasing level and
High-Density Lipoprotein (HDL) decreasing level were
observed. Dyslipidaemia that occur in this study lead to
insulin resistance. All cells insulin receptor can decrease
in downregulation system event due to high glucose in
blood. If these events occur continuously and
chronically, insulin receptor desensitization will happen.
It leads to a higher need blood plasma insulin to
incorporate glucose into cell tissue.
In this research, an increase in plasma insulin
levels in DM8 and DM16 groups occurred. That
conditions may increase insulin resistance incidence. By
using HOMA-IR rat formula it was found that insulin
resistance occurred in DM16 and DM8 groups (CI 95%;
sensitivity 83.87%; specificity 80.56%). DM8 group has
shown an increase in HOMA-IR value compared with
other groups, but has not been able to reach the cut-off
value. This shows that DM8 group is almost in insulin
resistance state or pre-diabetic condition. Abnormalities
in lipoprotein metabolism are also associated with type
2 diabetes and trigger atherosclerosis development.17
Glucose and lipid metabolism disorders are synergistic
in atherosclerosis development.18 In atherosclerosis,
vascular damage occurs as a result of inflammation and
oxidative stress.4,5 Metabolic disorders associated with
type 2 diabetes such as hyperglycaemia, AGEs
formation, increased FFA, and lipoprotein abnormalities
can induce vascular inflammation and promote
atherosclerosis progressivity.19
Lp-PLA2 is an enzyme that able to catalyze many
important biological reactions and allegedly played an
important role in atherosclerosis pathogenesis. Lp-PLA2
expression in this study tend to increase in type 2
diabetes condition and tend to decrease overtime
increment. This scheme shows Lp-PLA2 role in early
stages ofatherosclerosis. Darapladib administration in
this study had no significant effect on Lp-PLA2
expression. The increasing of Lp-PLA2 expression is
associated with ox-LDL level. A study shows that
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ox-LDL play an important role in atherosclerosis
pathogenesis and it is easy to form and increase in T2DM
state. 19 Ox-LDL level in this study is significantly
influenced by time series, darapladib treatment, and also
interaction between time series and darapladib treatment.
An increasing of ox-LDL level occurred in adipocytes
development, insulin resistance, and type 2 diabetes.20
LysoPC, the main products of Lp-PLA2 activity,
is a proatherogenic property of ox-LDL which can induce
proteoglycans synthesis and play an important role in
the intimal layer thickening of the endothelium. 21
LysoPC in this study is significantly infl uenced by time
series, darapladib treatment, and interaction between
time series and darapladib treatment. The increased of
Lp-PLA2 activity are also increase LysoPC levels that
are cytotoxic on blood vessels and smooth muscle
cells.22 Based on preclinical studies, darapladib is proven
to reduce atheroma which has LysoPC and some
expression of multiple genes related to macrophage and
T lymphocyte function in large enough quantities to the
plaque and necrotic core area.23 Research conducted by
Melissa et al in 2012 stated that the increased levels of
LysoPC occur at type 2 diabetes mellitus onset and
obesity condition.24
Lp-PLA2 has an anti-inflammatory role through
its ability to hydrolyze oxidized phosphatidylcholine and
PAF that are pro-inflammatory and pro-thrombotic. PAF
is a potent inflammatory agent that has a very important
role in atherosclerosis formation.25 In this study, PAF
levels were significantly (p<0.050) influenced by time
series, darapladib treatment, and interaction between
time series and darapladib treatment. Previous study
explained, darapladib and rilapladib can inhibit PAF
receptor, therefore reducing PAF biological activity, as
well as interfere with PAF biosynthesis.26
IL-6 is one of pro-inflammatory cytokine that
involved in atherogenesis. IL-6 in type 2 diabetes mellitus
condition can increase basal glucose uptake, alter insulin
sensitivity, improve adhesion molecule expression by
endothelial cells, have pro-coagulant effects on platelets,
and increase fibrinogen release by liver. In addition,
IL-6 is also capable of blocking lipoprotein lipase action
and stimulate lipolysis process.27 In this study, IL-6
expression were significantly (p<0.050) affected by
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darapladib treatment. While time series factor and
interaction between time series and darapladib treatment
does not significantly affect IL-6 expression (p>0.050)
(Figure 2). Increased Lp-PLA2 expression followed by
increased expression of cytokines IL-6 in type 2 diabetes.
Ox-LDL stimulate macrophages to phagocyte
lipid, then form a foam cell that signed the ongoing
process of atherogenesis.28 This study shows that foam
cells number was significantly (p<0.050) affected by
darapladib treatment. While the time series factor as well
as the interaction between time series and darapladib
treatment does not significantly affect the amount of
foam cell (p>0.050) (Figure 3). Foam cells formation
induced glucose indicates that glucose uptake is required
by cells, namely D-glucose (which is taken up by cells)
but not L-glucose (which can not be attached to cell
membrane) which then could induce macrophage
oxidative stress.29

Figure 2. Three immunofluorescence staining result of IL-6
using Fluorescein Isothiocyanate (FITC) secondary antibody.

Figure 3. Foam cells in different treatment groups of rats: (A) normal diet group 8 weeks; (B) T2DM 8 weeks; (C) T2DM
+ darapladib (20 mg/kgBW) 8 weeks; (D) normal diet group 16 weeks; (E) T2DM 16 weeks; and (F) T2DM + darapladib
(20 mg/kgBW) 16 weeks
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Conclusion
Darapladip is Lp-PLA2 inhibitor, it is lipophilic
and has a stupendous membrane permeability. Recent
studies explained that darapladip showed significant
result in inhibiting atherosclerosis process, whether by
in vitro or in vivo test.7-9 Darapladib were significantly
affected ox-LDL level tissue, PAF plasma, IL-6
expression and foam cells number.
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ABSTRACTS
Abstracts for Invited Lectures:
IL2.
CARDIOMYOCYTE TRANSPLANTATION IN ANIMAL
MODELS AND ITS SIGNIFICANCE FOR REGENERATIVE
MEDICINE
BK Fleischmann
Institute of Physiology I, University of Bonn, Life & Brain Center, Germany

conduction velocity within the scar area and a striking reduction of postinfarction ventricular tachycardia. Having said this, a major shortcoming of
current approaches are low rates of stable engraftment of cells. We are
addressing this by combining nanomedicine with cell replacement, in addition
we are using optogenetic approaches to modulate the electrical activity of
the heart with light and strategies to assess and enhance endogenous repair.

Myocardial infarction is characterized by an irreversible loss of
cardiomyocytes and this can result in heart failure. This disorder has a poor
prognosis and the only causal treatment currently available is heart
transplantation. Because of the shortage of donor organs, cell replacement
approaches using progenitors and/or stem cells are considered a promising
alternative approach. We have explored the potential of various progenitors
and stem cells to differentiate into cardiac muscle cells, their physiological
integration and contribution to pump function after engraftment into the
infarcted mouse heart. First, the plasticity of bone marrow-derived cells was
assessed and we found that these do neither differentiate into functional cardiac
muscle- or endothelial cells nor strongly enhance left ventricular function.
Similar results were obtained using bone marrow-derived mesenchymal stem
cells. In addition, the differentiation of these cells was not restricted by the
heart tissue as often calcifications and bone formation were observed. In
contrast, engrafted fetal cardiomyocytes and/or ES cardiomyocytes displayed
accelerated differentiation, intact cellular function at the single cell level;
these cells led to an improvement of left ventricular function and a reduction
of mortality rates of mice. Next, the electrical integration of grafted
cardiomyocytes into the cardiac syncytium was determined. The experiments
revealed that engrafted cardiac muscle cells can electrically couple with the
native heart muscle via connexin 43. Their engraftment results in an increased

IL4.
SURGERY OF CONGENITAL HEART DISEASES: IS
STRUCTURE REPAIR ASSOCIATED WITH MOLECULAR
CHANGES?
GW He,1,3 HT Hou,1 C Xuan,1 J Wang,1 XC Liu,1 Q Yang1,2
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
Sciences & Peking Union Medical College, Tianjin & The Affiliated Hospital
of Hangzhou Normal University & Zhejiang University, China; 2The Chinese
University of Hong Kong, Hong Kong; 3Department of Surgery, Oregon Health
and Science University, USA
1

p-component (p<0.05) was completely recovered. In TOF patients,
postoperative gelsolin (p<0.05) was partially and alpha-1-antitrypsin
(p<0.01) was completely recovered. In contrast, the elevated fibrinogen
gamma chain level in preoperative patients (p<0.01) became normal
postoperatively (p=0.1 vs. control).
Conclusions: We have for the first time, by using proteomic methods
demonstrated that repair surgery for CHD not only corrects the structure
malformation of the heart but also resumes the molecular normality. The
degree of the recovery of protein or other molecules may provide useful
information for "Precision Medicine" in the management of these patients.

Purpose: The final goal for treatment of congenital heart diseases (CHD) is
to resume not only the normal heart structure but also normal life towards
"Precision Medicine". The present study explores the surgical results at
molecular basis on the proteomic pattern in the pre- and post-operative period
in tetralogy of Fallot (TOF) and ventricular septal defect (VSD) in order to
find whether structure repair is associated with clinically important molecular
changes in CHD.
Methods: Differential protein analysis by using two-dimensional gel
electrophoresis and mass spectrometry followed by ELISA was performed
in the plasma samples of patients with TOF (n=82) or VSD (n=82)
preoperatively, 6-month postoperatively, and normal controls (n=82).
Results: A total of 473 protein spots in preoperative patients and 515 in
postoperative patients were detected. Significantly (p<0.01) downregulated
and upregulated protein spots were detected. Validation of proteins in the
new group of patients demonstrated that in VSD patients, postoperative
Complement Component C3c (p<0.05) was partially and serum amyloid
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ABSTRACTS
Abstracts for Invited Lectures:
IL5.
PERSONAL VIEWPOINTS ABOUT CARDIOVASCULAR
SCIENCES AND MEDICINE DURING THE PAST TWO
DECADES
CY Kwan
Shantou University, China
Solving problems in cardiovascular (CV) diseases has always been a core
objective in clinical medicine, which requires integration of research and
education, in analogous to the functional coordination of our left and right
limbs. My 30-year satisfying research life in vascular biology in a successful
Smooth Muscle Research Program at McMaster has taught me to appreciate
such an integration. Research dominated a large part of my young adult life,
struggling through ladders of academic promotion and achieving bits of fames
here and there, which still remain the dreams, and also, nightmares for many
young researchers these days. I had them all and felt satisfied with what I
have got. I do not know how I did it. I simply worked hard, but not as a loner.
I had many helping hands along the path. I could have done with greed for
more, but I shifted my career path, unknowingly, perhaps due to a cultural
inspiration, which prompted me to take a leave of absence from McMaster
University in 1992, move to the East and take up the Physiology Chair position
at the University of Hong Kong (HKU), and subsequently helped build ICSM
there. This swift marked a milestone in my academic career, not just in CV
sciences, but in medicine as a whole. Being academically trained in the West
as a vascular biologist transforming my early self as a chemist, I developed a
profound interest in Chinese medicinal herbs as folk medicine, especially
those treating circulatory diseases. I began curious in herbal medicine that
displayed vasoactive and antihypertensive actions and to relate I my research
findings to the Chinese medicinal theories and its practice. My academic
duty as a teacher at McMaster University lured me into educational wonderland

of problem-based learning (PBL). Against all odds, I managed to help bring
PBL into HKU 20 years ago at the time when ICSM was also established.
I then professed PBL in the Asia Pacific countries, subsequently in Taiwan
and now in China and helped form the Asia Pacific Association for PBL in
Health Sciences in 2000 (still functional and active, like ICSM). In PBL for
medicine, CV sciences is not a simple organ system discipline composed of
knowledge-oriented Life sciences ("L" in PBL), it must be multi-disciplinary
and integrated with Population perspectives ("P" in PBL) dealing with family,
community and global issues, and Behavioral perspectives ("B" in PBL)
dealing with attitudes, ethics and living styles. Thus, my personal view about
CV sciences represent a close academic integration of research and
education, as well as an system integration that governs the body circulation
to multiple organs and an content integration of population, behavioral and
living-the-life perspectives.

IL6.
ZERO-TIME EXERCISE AND ANTI-INERTIA REMINDER
(AIR) MODEL: THE HONG KONG JOCKEY CLUB FAMILY
PROJECT
TH Lam, A Wan, HCY Ho, G Lau, A Lai
School of Public Health, The University of Hong Kong, Hong Kong
Obesity is increasing globally and physical inactivity is still prevalent. We
propose "Zero-time Exercise" as a new approach to promote physical activity
(PA), family exercise and well-being in Phase Two of The Hong Kong Jockey
Club FAMILY project. We use a public health approach and positive
psychology, and collaborate with government and many NGOs to design,
implement and evaluate many simple and low-cost community based projects
which are evidence-based and evidence-generating, for thousands of
participants (See www.family.org.hk, or YouTube for details). "Zero-time
Exercises" (ZTEx) are easy, enjoyable and effective (3Es) and can be done
with zero time, zero money and zero equipment (3 Zeros) by anybody, anytime
and anywhere (3As). ZTEx are simple movements and stretches that can be
done while sitting, standing and walking. One good example is to raise both
legs above the ground, and do pedaling while sitting. We have been running
several major projects in collaboration with government and NGO partners
and the preliminary results are encouraging. We use a participatory and
interactive approach to engage the participants in our presentations and
workshops. To begin with, we ask and all or almost all participants reply that
they do not have enough exercise or PA and the main reasons are being lazy
or too busy (i.e. having no time). They understand the harms of physical
inactivity such as sitting too much and the benefits of exercises. They all
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pledge to do ZTEx because they want to be healthier and fitter, and to share
with their family members because they love them. Although ZTEx should
be a foot-in-the-door approach for an easy behavioural change, we recognize
that forgetfulness and/or inertia are major barriers. We propose the Antiinertia Reminder (AIR) Model which states that, for simple actions and
behavior changes that the participants understand, accept, have tried and
enjoyed during the learning process, and have pledged to act to benefit
themselves and their families, simple, direct and frequent reminders would
motivate the participants to overcome the inertia, leading to immediate simple
actions and more sustained behaviour changes with the simple actions
integrated into daily life. We have conducted several simple and brief (from
15-60 minutes) one-session interactive workshops on ZTEx and used AIR
(several reminders within a session) to motivate participants to do ZTEx (leg
raising and/or pedaling) during the whole period of the session. We told the
participants that our research staff would observe and count how many who
did so. We also asked the participants to raise their hands if they had done
ZTEx while sitting and listening. We recorded our observations and/or their
responses and presented these results in charts showing ZTEx responses
against time.
Preliminary Results: Most participants responded actively, enjoyed the
session and showed great appreciation. AIR increased ZTEx in varying
percentages of participants at different time points during the workshops.
The immediate effects were easily observed for the active participants, while
a minority of them appeared to be quite non-responsive. Further analysis and
follow-up are in progress.
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Abstracts for Invited Lectures:
IL7.
TREATMENT OF CARDIAC FIBROSIS BY TARGETING
TGF-BETA/SMAD SIGNALLING
HY Lan
Department of Medicine and Therapeutics, and Li Ka Shing Institute of Health
Sciences, The Chinese University of Hong Kong, Hong Kong
It is now well accepted that TGF-β/Smad signaling is a major pathway leading
to cardiac fibrosis. Among this pathway, we found Smad3 is pathogenic,
while Smad7 is protective because deletion of Smad3 protects against but
disrupted Smad7 enhances hypertensive cardiac remodeling and functional
injury in a mouse model of hypertension induced by subcutaneous angiotensin
II infusion. Next, we examined the mechanism by which Smad3 mediates
cardiac fibrosis by RNA-seq and found that deletion of Smad3 prevents a
loss of miR-29 family, suggesting that the miR-29 family is the downstream
target of Smad3 and Smad3 mediates cardiac fibrosis by downregulating miR29 expression. We then develop novel therapeutic strategies by targeting
Smad3 signaling with a Smad3 inhibitor or by overexpressing Smad7, or by
restoring miR-29b. All therapeutic strategies demonstrate that blockade of
Smad3 directly with a Smad3 inhibitor or by overexpressing Smad7 is capable
of inhibiting cardiac inflammation and fibrosis in the hypertensive heart
disease. In addition, we also find that overexpression of miR-29b is able to
blocking angiotensin II-induced cardiac fibrosis by inhibiting TGF-β/Smad3
signaling, suggesting a feedback loop of TGF-β/Smad3-miR-29 in regulating
Ang II-induced cardiac fibrosis. In summary, TGF-β/Smad3 signaling is a
key pathway leading to cardiac fibrosis and targeting this pathway by a Smad3
inhibitor, Smad7, or miR-29 may represent a novel and specific therapy for
cardiac fibrosis.
(This work is supported by RGC GRFs and CRF (CUHK3/CRF/12R) and Lui
Che Woo Institute of Innovative Medicine - CARE Research Fund (8303307).
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PROTEOMIC STUDY IN THE PLASMA OF PATIENTS WITH
ISOLATED PATENT DUCTUS ARTERIOSUS AND
POTENTIAL CLINICAL SIGNIFICANCE
HT Hou, 1,2 J Wang, 1 X Zhang, 1 HX Chen, 1 Q Yang, 1,3 GW He1,2,4
1
Department of Cardiovascular Surgery & Center for Basic Medical Research,
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
Sciences, China; 2The Affiliated Hospital of Hangzhou Normal University&
Zhejiang University, China; 3The Chinese University of Hong Kong, Hong
Kong; 4Department of Surgery, Oregon Health and Science University, USA

processes, and cellular components. The five validated proteins in PDA
patients may play key roles in the platelet aggregation, innate and adaptive
immune response, coagulation mechanism, and the activation of complement
system, and therefore have clinical significance.

Purpose: Patent ductus arteriosus (PDA) is the third most common congenital
heart disease (CHD) in which the arterial duct, normally closed spontaneously
after birth within 24-48h in full-term infants, remains permanently open.
This study was aimed to reveal the differential plasma proteins in isolated
PDA patients compared with normal controls.
Methods: Isobaric tags for relative and absolute quantitation (iTRAQ) and
enzyme-linked immunosorbent assay (ELISA) were used to detect differential
plasma proteins (n=60 respectively).
Results: A total of 172 differential plasma proteins were found to be
statistically significant, five proteins (platelet factor 4, von Willebrand factor,
complement 9, mannose binding lectin-associated serine protease-2 and
fibronectin), seemed to be associated with PDA, were selected for validation.
We found that fibronectin was up-regulated and the other four were downregulated (p<0.05 vs. control).
Conclusion: The present study for the first time by using the iTRAQ
proteomic technology in CHD-PDA patients identified a large number of
differential plasma proteins that are related to molecular function, biological

OP2.
ZINC MEDIATES MITOCHONDRIA-ENDOPLASMIC
RETICULUM "CROSSTALK" IN MORPHINE-INDUCED
CARDIOPROTECTION AGAINST ISCHEMIA/
REPERFUSION INJURY
MY Xi, YG He, P Wang, Y Fu, ZL Xu, JK Xi
Heart Institute, North China University of Science and Technology, China
Our previous studies showed that reperfusion but not ischemia initiates
endoplasmic reticulum stress (ER stress) and inhibition of ER stress protects
the heart from reperfusion injury through prevention of the mitochondrial
permeability transition pore (mPTP) opening via intracellular Zinc. We aimed
to explore whether Zinc was involved in morphine-induced cardioprotection
against ischemia/reperfusion injury and to explore the potential mechanism.
Morphine given at reperfusion significantly decreased the expression of the
ER stress chaperones GRP78 and GRP94 in isolated rat hearts, which were
reversed by the Znic chelator TPEN, indicating that morphine could suppress
the reperfusion-induced ER stress through Zinc. The immunofluorescence
study with confocal microscope also support this effect. Experiments with
infarct size study revealed that morphine could mimic the ER stress inhibitor
TUDCA by significantly reducing the infarct size (21.3±6.7%) in isolated
rat hearts subjected to 30 minutes regional ischemia followed by 2 hours of
reperfusion. Transmission electron microscopy and hematoxylin-eosin staining
showed that morphine could prevente endoplasmic reticulum and
mitochondrial damages at reperfusion, which were abrogated by TPEN,
implying that morphine may protect the heart at reperfusion through inhibition
of ER stress via Zinc. H9c2 cardiac cells treated with 2-DG, the ER stress
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inducer, showed a significant decrease (47.2±6.9%) in TMRE fluorescence
compared to the normal group (96.4±5.1%), indicating that ER stress induces
the mPTP opening. Morphine could mimic the effects of TUDCA, ZnCl2 and
mPTP inhibitor cyclosporin A by significantly inhibiting of the loss of TMRE
fluorescence. In support, morphine and TUDCA could mimic ZnCl 2 by
increasing the fluorescent Zinc indicator Newport green DCF. The effects of
morphine on TMRE and Newport green DCF were inhibited by TPEN,
indicating that morphine prevents the mPTP opening through inhibition of
ER stress via increasing the intracellular free Zinc. In conclusion, these data
suggest that morphine protects the heat from reperfusin injury through
inhibition of ER stress by prevention of the mPTP opening. Increased
intracellular free Zinc accounts for the mitochondria-endoplasmic reticulum
"CROSSTALK".
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ZERO TIME EXERCISE: A CLUSTERED RANDOMIZED
CONTROLLED TRIAL TO PROMOTE PHYSICAL ACTIVITY,
HEALTH, HAPPLINESS, AND FAMILY HARMONY UNDER
HONG KONG JOCKEY CLUB FAMILY PROJECT
AYK Lai,1 ANT Wan,1 DPK LEE,2 TH Lam1
School of Public Health, The University of Hong Kong; 2Family Service,
Caritas, Hong Kong
1

Objectives: About half of Hong Kong people are physically inactive. "Zerotime Exercise" (ZTEx) is a new approach to motivate people to do simple
exercises, which need no extra time (zero time ), money or equipment, and
suit anybody, anytime and anywhere (3As). This cluster randomized controlled
trial examined the effects of a ZTEx community intervention.
Methods: All the eight Caritas Integrated Family Services Centres with their
respective community participants were randomized into either a physical
activity experimental (PA) group or a control group (4 centres per group).
We aimed to enhance the PA participants' physical activity by increasing their
knowledge, motivation and self-efficacy about ZTEx through a 2-hour
interactive core session at baseline, a 1.5-hour booster session at 3 months,
and six monthly mobile messages. The control group had healthy diet (HD)
intervention with the same methods, number of sessions and duration. Primary
outcome was the number of days per week in doing ZTEx. Secondary
outcomes were personal health, happiness, and family harmony. Each item
allowed response on a 0 to 10 scale ranging from "not at all healthy/ happy/
harmonious" to "very healthy/ happy/ harmonious". We analysed by intentionto-treatmethod.
Results (preliminary): 673 participants (92% female) with at least one child,
were recruited into the PA experimental group (n=357) or HD control group
(n=316). Both groups had increased ZTEx [PA group: from 2.3 to 5.0 days/

week (Cohen's d=1.14, p<0.001) at three months, and at six months; HD
group: from 2.6 to 3.7 days/week (Cohen's d=0.44, p<0.001) at three months
and 3.8 days/week (Cohen's d=0.49, p<0.001) at six months]. Both groups
also had better perceived personal health [PA group: from 4.8 to 5.8 and 6.0
units; HD group: from 4.8 to 5.5 and 5.8 units), happiness (PA group: from
5.8 to 6.5 and 6.6 units; HD group: 5.4 to 6.0and 6.3 units), and family
harmony (PA group: 6.2 to 6.8 and 6.9 units; HD group: 5.8 to 6.4 and 6.5
units) at three months, and at six months (all p<0.001), respectively.
Comparing with the HD control group, the PA experimental group performed
more ZTEx by 1.3 days/week (Cohen's d = 0.75, p<0.001), and had greater
improvements in perceived personal health by 0.2 unit (Cohen's d =0.21,
p=0.007) and family harmony by 0.2 unit (Cohen's d=0.17, p=0.036) at three
and six months, adjusting for age, gender, education, income, marital status
and their baseline values.
Conclusions: Our ZTEx intervention showed preliminary evidence of
effectiveness in increasing physical activity, personal health, happiness and
family harmony.

OP4.
UPREGULATION OF ATROGIN-1 PERK IN RESPONSE TO
ER STRESS MEDIATES BK ca CHANNEL DYSFUNCTION
INDUCED BY HOMOCYSTEINE IN CORONARY ARTERIES
WT Sun, XC Wang, SK Mak, J Fu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, Faculty of Medicine, The Chinese University of Hong
Kong, Hong Kong
Background & Objectives: Although previous studies reported the inhibitory
effect of homocysteine on large-conductance Ca 2+-activated K + (BK Ca)
channels in vascular smooth muscle cells, the mechanisms by which
homocysteine inhibits BKCa channels remain poorly studied. Endoplasmic
reticulum (ER) stress plays a role in various cardiovascular diseases though
the cellular and molecular bases of ER stress in vascular pathology are
inadequately elucidated. Whether ER stress affects BKCa channels and BKCa
channel-mediated vasodilatory function so far remains uninvestigated. This
study aimed to reveal whether ER stress regulates smooth muscle BK Ca
channels to participate in coronary dysfunction induced by homocysteine,
with further uncovering the molecular determinants involved in the regulation.
Methods: Primary cultured porcine coronary arterial smooth muscle cells
(PCASMCs) were used for mRNA and protein analysis of BKCa channels, as
well as patch-clamp recording of the BKCa channel current. Vasorelaxant
response to the BKCa channel opener NS1619 was studied in endotheliumdenuded porcine small coronary arteries in a myograph.
Results: Homocysteine lowered protein level of BKCa β1 subunit whereas
showed no effect on α subunit in PCASMCs. NS1619-induced vasorelaxtant
response of coronary arteries was attenuated by homocysteine. Inhibition of
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ER stress preserved the protein content of BK Ca β1 and NS1619-evoked
vasorelaxation. The selective inhibitor of PKR-like ER kinase (PERK)
GSK2606414 showed similar protective effect against homocysteine as ER
stress inhibitors on BKCa β1 expression and NS1619-induced relaxation, along
with a significant enhancement of BKCa channel current. The restoration of
BKCa β1 by PERK inhibition was associated with reduced atrogin-1 expression
and decreased nuclear localization of forkhead box O transcription factor 3a
(FoxO3a). Silencing of atrogin-1 prevented homocysteine-induced loss of
BK Ca β1 and silencing of FoxO3a prevented atrogin-1 upregulation in
homocysteine-exposed PCASMCs, accompanied by preservation of BKCa β1
protein level and BKCa channel current.
Conclusions: ER stress mediated homocysteine-induced BK Ca channel
inhibition in coronary arteries. Activation of FoxO3a by PERK branch
underlies the ER stress-mediated BK Ca inhibition through a mechanism
involving ubiquitin ligase-enhanced degradation of the channel β1 subunit.
(Supported by RGC/GRF CUHK14118414; Lui Che Woo Institute of
Innovative Medicine - CARE theme 8303303, and CUHK Direct Grant
4054182)
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OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY
AFTER DRUG-ELUTING STENT IMPLANTATION:
NETWORK META-ANALYSIS OF RANDOMISED
CONTROLLED TRIALS
Y Fei, MF Tsoi, TT Cheung, BMY Cheung
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong
Objectives: The optimal duration of dual antiplatelet therapy (DAPT) after
drug-eluting stent (DES) implantation has always been debated. Evidence
from clinical trials directly comparing short-term (<12 months) and extended
(>12 months) dual antiplatelet therapy is limited. So we performed a network
meta-analysis to assess the risks and benefits of different DAPT durations to
guide clinical practice.
Methods: We searched MEDLINE, EMBASE, Scopus, ISI Web of Science,
Cochrane Library, ClinicalTrials.gov and recent conference proceedings for
clinical trials and included those randomising patients to receive different
durations of DAPT after DES implantation and reporting frequencies of
cardiovascular and bleeding events. Network meta-analysis was performed
with both a frequentist approach and a Bayesian framework using R statistics.
Heterogeneity was calculated using I2 statistics; bias in the selection or
publication of studies was assessed.
Results: Twelve randomised controlled trials with 34920 patients were
included. Four trials compared extended DAPT (>12 months) vs. 12 months'
regimen, seven trials compared short-term DAPT (<12 months) vs. 12 months'
regimen and one trial compared extended vs. short-term DAPT. Extended
DAPT significantly reduced the frequencies of myocardial infarction
(OR 0.56, 95%CI 0.46-0.68 and OR 0.58, 95%CI 0.44-0.77), and stent

thrombosis (OR 0.44, 95%CI: 0.30-0.65 and OR 0.49, 95%CI 0.29-0.82)
when compared to 12 months' and short-term DAPT, respectively. However,
the risk of major bleeding (OR 1.53, 95%CI 1.21-1.93 and OR 2.58, 95%CI
1.62-4.10) was substantially increased. Extended DAPT also increased the
risk of all-cause mortality (OR 1.27, 95%CI 1.03-1.57) when compared to
12 months' DAPT. No significant difference was found in cardiovascular
mortality, stroke and repeat revascularisation.
Conclusions: Our network meta-analysis with the latest available evidence
suggests that 12 months' DAPT appears to be a reasonable compromise
between preventing stent thrombosis and increasing bleeding risk. The
decreased major bleeding with short-term DAPT than extended DAPT is offset
by increased myocardial infarction and stent thrombosis. Patients at high
bleeding risk could have a shorter DAPT duration; those with low bleeding
but high ischaemic risk could consider a longer duration.

OP6.
DISTURBED FLOW ACTIVATES TLR4 AND INDUCES
ENDOTHELIAL INFLAMMATION
D Qu, CW Lau, L Wang, W Song, J Xu, XY Tian, Y Huang
School of Biomedical Sciences and Institute of Vascular Medicine, The
Chinese University of Hong Kong, Hong Kong
Objectives: The endothelium governs the health of blood vessels, while its
dysfunction plays a critical role in both the initiation and progression of
cardiovascular diseases including atherosclerosis. Disturbed flow of blood at
arterial branches and curvatures directly modulates endothelial physiology
and predispose the region to endothelial dysfunction and development of
atherosclerotic lesions. Emerging experimental and clinical evidences show
that activation of the Toll-like receptors (TLRs), in particular TLR4,
contributes to vascular inflammation and atherosclerosis. However, whether
TLR4 participates in the disturbed flow-induced endothelial dysfunction and
inflammation has not been studied yet.
Methods: Tlr4 mut mice were used to investigate the role of TLR4 under
disturbed flow in vivo. Partial carotid ligation was performed to induce
disturbed flow in left common carotid in mice. Proximity ligation assay was
used to detect interaction between target proteins in endothelial cells.
Results: An expression profile and functional assessment of TLRs have been
provided, demonstrating that TLR4 was the dominant among TLR family
members in vascular endothelial cells. TLR4 expression, activation, and its
downstream inflammatory markers were elevated in mice aortic arch
compared to thoracic aorta, which were absent in the Tlr4mut mice. The same
results were observed in partial carotid ligation models where TLR4 signaling
was activated in response to ligation-induced flow disturbance and also
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reversed by the TLR4 mutant. Disturbed flow in vitro increased TLR4
expression and activation in ECs and promoted monocyte-endothelial cell
adhesion, which were inhibited in TLR4 deficient ECs. Moreover, of
endogenous TLR4 ligands examined as candidate mediators of disturbed flowinduced TLR4 activation, fibronectin containing the extra domain A (FNEDA) expressed by endothelial cells was increased by disturbed flow and
identified to directly interact and activate TLR4.
Conclusions: Our results demonstrates for the first time an indispensable
role of TLR4 in disturbed flow-induced endothelial inflammation which may
serve as the critical initiating step in atherogenesis, and pinpointed FN-EDA
as an endogenous mediator that transfers the haemodynamic force to TLR4
activation.
(Supported by CUHK2/CRF/12G, GRF14105814, NSFC91339117 and CUHK
Lui Che Woo Foundation)
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DEFICIENCY OF PROSTAGLANDIN E 2 RECEPTOR
SUBTYPE 4 CAUSES DYSREGULATION OF CHOLESTEROL
HOMEOSTASIS IN MICE
F Ying,1 Y Cai,2 EHC Tang1,3
1
Department of Pharmacology and Pharmacy; 2 Department of Anesthesiology,
3
School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong
Mice lacking prostaglandin E2 (PGE2) receptor subtype 4 (EP4), one of the
four receptors identified for prostaglandin E 2 developed spontaneous
hypercholesterolemia. The present study investigated the cause of the elevated
plasma cholesterol in EP4 knockout mice. 15-17 weeks old normal diet-fed
EP4 knockout mice showed a 48% increase in total cholesterol, 84% increase
in very low density lipoprotein (VLDL)-low density lipoprotein (LDL) and
15.6% increase in high density lipoprotein (HDL), as compared to their
wildtype littermates. The increase in plasma cholesterol is unrelated to
alteration in intestinal cholesterol absorption, as fecal neutral sterol excretion
did not differ between the two stains of mice. Rather, it was due to an increase
production and efflux of cholesterol from the liver. The absence of EP4
increased protein expression of hepatic cholesterol efflux transporters,
including ATP-binding cassette (ABC) A1 (by 61.33%) and ABCG1
(by 64.73%) and reduced phosphorylation of 3-hydroxy-3-methylglutaryl
coenzyme A reductase (HMG-CoA reductase; by 81.52%) and in so doing
increased HMG-CoA reductase activity (by 170.36%), the rate-limiting
enzyme for cholesterol synthesis. These effects were confirmed in human
hepatoma (HepG2) cell line with EP4 knockdown. EP4 activators (CAY10580
and PGE 2), cyclic AMP (cAMP) and protein kinase A (PKA) activators
(8-Br-cAMP and 6-MB-cAMP, respectively) increased HMG-CoA reductase
phosphorylation, while pre-treatment with H89 (a selective PKA inhibitor)

r e v e r s e d t h e P G E 2 - m e d ia t e d i n c r e as e i n H M G - C o A r e d u c t as e
phosphorylation. These findings reveal that EP4 regulate cholesterol levels
through a cAMP-PKA signaling axis and modulate the phosphorylation status
of HMG-CoA reductase. In summary, the hypercholesterolemia in EP4
deficient mice is caused by an increase in cholesterol synthesis and cholesterol
efflux from the liver. EP4 deficiency results in an inability to maintain normal
plasma cholesterol levels in mice, identifying a new metabolic dimension in
the physiological role played by endogenous EP4.
(This work is supported by The Research Grant Council Early Career Scheme
(ECS) Project code: 27101314)

OP8.
INHIBITION OF sEH UPREGULATION BY ALLEVIATING
ER STRESS CONTRIBUTES TO THE ENDOTHELIAL
PROTECTIVE EFFECTS OF TETRAMETHYLPYRAZINE
SK Mak, WT Sun, J Fu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, Faculty of Medicine, The Chinese University of Hong
Kong, Hong Kong
Background & Objectives: Soluble epoxide hydrolase (sEH) is a key
endogenous enzyme in the metabolism of epoxyeicosatrienoic acids. Despite
numerous studies reporting the role of sEH upregulation in endothelial
dysfunction, the mechanisms by which sEH is upregulated are still
inadequately understood. It remains uninvestigated whether endoplasmic
reticulum (ER) stress is involved in sEH dysregulation. Tetramethylpyrazine
(TMP) is a major active ingredient of Chinese herb Chuanxiong that has
been long known for cardiovascular benefits. However, whether TMP may
protect vascular endothelial cells from ER stress and whether it may regulate
sEH expression remain unknown. The present study therefore aimed to
investigate whether ER stress participates in angiotensin II (Ang-II)-induced
sEH dysregulation in coronary endothelium and whether anti-ER stress
mechanism is involved in the vasoprotective effect of TMP through the
regulation of sEH.
Methods: Endothelial cells (PCECs) were isolated by enzymatic digestion
from porcine coronary arteries (PCAs) and primary cell cultures were used
for western blot and reverse-transcription PCR analysis. Isometric force study
of PCAs was performed in a myograph for assessment of endothelial dilator
function.
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Results: Ang-II induced upregulation of sEH at mRNA and protein level in
PCECs, associated with increased expression and phosphorylation of ER stress
molecules, i.e., GRP78, ATF6, p-PERK, and p-IRE1α. The increases of sEH
mRNA and protein were also observed in PCECs exposed to tunicamycin, a
chemical ER stress inducer. Pretreatment of PCECs with ER stress inhibitors
suppressed Ang-II-induced upregulation of sEH. TMP showed comparable
inhibitory effect to that of ER stress inhibitors on Ang-II and tunicamycininduced expression/phosphorylation of ER stress molecules and upregulation
of sEH. PCAs subjected to Ang-II and tunicamycin exposure exhibited
impaired endothelium-dependent relaxation, which was improved by
inhibitors of ER stress and sEH. TMP was similarly efficient as ER stress
inhibitor in the restoration of endothelium-dependent relaxation in Ang-IIand tunicamycin-exposed PCAs.
Conclusions: Our results reveal that TMP possesses anti-ER stress properties
and inhibition of sEH upregulation by alleviating ER stress is involved in
the protective effects of tetramethylpyrazine against Ang-II-induced coronary
endothelial dysfunction. These findings added new mechanistic insight into
the cardiovascular benefits of this traditional Chinese medicine.
(Supported by RGC/GRF CUHK14118414; Lui Che Woo Institute of
Innovative Medicine - CARE theme 8303303, and CUHK Direct Grant
4054273)

October 2016

83

ICSM, THE TWENTIETH ANNIVERSARY SCIENTIFIC MEETING
ABSTRACTS
Abstracts for Chaired Posters:
CP1.
TREATMENT OF CALCIUM CHANNEL BLOCKER
OVERDOSE: A CASE SERIES
MF Tsoi,1 TT Cheung,1,2 BMY Cheung1,2,3,4
1
Division of Clinical Pharmacology and Therapeutics, Department of
Medicine; 2Research Centre of Heart, Brain, Hormone and Healthy Aging;
3
Institute of Cardiovascular Science and Medicine; 4The State Key Laboratory
of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong

groups. Compared to death patients, survived patients had higher baseline
serum albumin level (p=0.019). However, baseline serum albumin level was
not associated with mortality of patients (adjusted odds ratio: 0.670; 95%
Confidence interval: 0.435-1.032).
Interpretation: Calcium channel blocker overdose may induce death. High
dose insulin did not improve survival rate in patients with calcium channel
blocker overdose and treatment failure by intravenous calcium salt infusion.
Baseline serum albumin was not predictor for mortality.

Introduction: Calcium channel blocker is a class of anti-hypertensive
medications. However, its overdose may induce hypotension, shock and death.
There was limited evidence in efficacy of high dose insulin (HDI) as supportive
therapy in patients with calcium channel blocker overdose. Therefore, there
is a need to study the survival of HDI treatment in patients with calcium
channel blocker overdose.
Method: The Poison Information and Clinical Management System was used
to identify patients with calcium channel blocker overdose. For inclusion,
patients must be documented with calcium channel blocker overdose,
hypotension and failed intravenous calcium salt. Patients were stratified
according to the treatment regimen received by patients. The outcome of this
study was the survival after treatment. Results were analysed by SPSS version
23.0. Logistic regression was used to study association between baseline
parameters and mortality.
Result: 17 patients were included into this study. The mortality rate of patients
were 38.5% and 0% in patients with HDI treatment and patients without
HDI treatment, respectively (p=0.152). There is no significant difference in
terms time-to-event relationship in death of patients (p=0.594) between two

CP2.
SERUM 25-HYDROXYVITAMIN D AND THE RISK OF
STROKE IN HONG KONG CHINESE
RYH Leung,1,2 Y Han,1 CW Sing,1 BMY Cheung,2,3 ICK Wong,1,5 KCB Tan,2
AWC Kung,2 CL Cheung1,3,4
1
Department of Pharmacology and Pharmacy; 2Department of Medicine; 3The
State Key Laboratory of Pharmaceutical Biotechnology; 4Centre for Genomic
Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Hong Kong; 5Research Department of Practice and Policy, UCL School of
Pharmacy, United Kingdom

The association between vitamin D and risk of stroke was in a reverse
J-shape in penalized regression spline, with the lowest risk of stroke being
observed at 25(OH)D levels between 70 and 80 nmol/L.
Conclusion: A low vitamin D level is associated with higher risk of ischemic
stroke. Further study is needed to evaluate whether high vitamin D level is
also associated with increased risk of stroke.

Objectives: Vitamin D level has been linked to the risk of cardiovascular
diseases, however, its association with stroke remains inconclusive. In this
study, we aimed to evaluate the association between serum 25-hydroxyvitamin
D and risk of stroke in Hong Kong Chinese.
Methods: This study included 3,458 participants from the Hong Kong
Osteoporosis Study aged 45 and older at baseline. They were examined
between 1995 and 2010 and followed up using electronic medical records.
Ischemic and hemorrhagic stroke were defined using ICD-9 codes.
Results: Quintiles 1 and 4 of 25-hydroxyvitamin D were significantly
associated with increased risk of stroke when compared to the highest quintile
(Quintile 1: HR, 1.78; 95% CI, 1.16-2.74 and quintile 4: HR, 1.61; 95% CI,
1.07-2.43) using multivariable Cox-proportional hazard regression. A similar
association was observed in both genders. In subgroup analysis, the association
was specifically observed for ischemic stroke, but not hemorrhagic stroke.
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GLP-1 ANALOGUE EXENDIN-4 PROTECTS AGAINST
HOMOCYSTEINE-INDUCED OXIDATIVE STRESS AND
ENDOTHELIAL DYSFUNCTION IN RAT ARTERIES
CK Cheng, CW Lau, D Qu, XY Tian, Y Huang
School of Biomedical Sciences and Institute of Vascular Medicine, Chinese
University of Hong Kong, Hong Kong
Homocysteine is associated with many cardiovascular and metabolic diseases
including hypertension and type 2 diabetes mellitus. High circulating
homocysteine can trigger endoplasmic reticulum stress and causes excessive
reactive oxygen species (ROS) production in endothelial cells. Elevated
oxidative stress inactivates the function of the major endothelium-derived
vasodilator nitric oxide (NO), resulting in endothelial dysfunction which is
the hallmark of numerous cardiovascular complications. Secreted by intestinal
endocrine L-type cells, the proglucagon-derived hormone glucagon-like
peptide 1 (GLP-1) binds to GLP-1 receptors on endothelial cell surface to
restore normal endothelial function by lowering vascular oxidative stress.
Nevertheless, GLP-1 is subjected to rapid dipeptidyl peptidase 4 (DPP-4)mediated degradation. It thus demands the development of other stable GLP1 analogues such as exendin-4. Although exendin-4 can repair endothelial
injury by restoring NO bioavailability, it remains unclear whether exendin-4
can protect endothelial cells in the presence of the cardiovascular risk factor
homocysteine. Therefore, the present study aims to investigate whether
exendin-4 reduces homocysteine-induced endothelial dysfunction through
inhibiting oxidative stress in aortas from SD rats. Exendin-4 (1-100 nM)
reverses homocysteine-induced impairment of endothelium-dependent
relaxations in response to acetylcholine. Exendin-4 also inhibits the elevated

accumulation of ROS in endothelial cells and the vascular wall of rat aortas
triggered by homocysteine (300 µM). Future experiments are needed to
confirm the in vitro vascular benefit of exendin-4 in the rat model of
hyperhomocysteinemia to better understand any new mechanisms by which
GLP-1 analogues protect vascular function under pathological conditions.
The new findings shall shed new light on the potential use of these agents in
the treatment of homocysteine-related cardiovascular diseases.
(This study is supported by CUHK Direct Grant and CUHK Lui Che Woo
Foundation)

CP4.
CONNEXIN 43, PANNEXIN 1 AND CYSTIC FIBROSIS
TRANSMEMBRANE CONDUCTANCE REGULATOR IN THE
REGULATION OF ATP RELEASE FROM MUSCLE
ETH Wu, L Lu, YS Wang, HJ Ballard
School of Biomedical Sciences, The University of Hong Kong, Hong Kong
ATP release from contracting skeletal muscle cells makes an important
contribution to the increased blood flow that accompanies muscle contractions.
Muscle contractions stimulate the formation of lactic acid, and the resulting
decrease in intracellular pH stimulates the release of ATP. We studied the
mechanism of lactic-acid-induced ATP release in the L6 skeletal myoblast
cell line (which is a model for neonatal muscle) and in myofibres isolated
from adult rat skeletal muscle. Lactic acid stimulated ATP release from
myoblasts or isolated muscle fibres; in myoblasts, acidosis-induced ATP
release could be inhibited by niflumic acid, lanthanum, or 100 µM
carbenoxolone, but not by probenecid or 10 µM carbenoxolone, suggesting
that connexins mainly mediated the ATP release. Lucifer yellow uptake into
myoblasts was strongly stimulated in a Ca-free medium, but not in high
potassium, confirming that connexins rather than pannexins were opened in
this model. Cx43 siRNA reduced extracellular ATP of myoblasts to less than
20% of control, in the presence or absence of lactic acid, suggesting that
Cx43 mediated the majority of ATP release. Lactic-acid-induced ATP release
was inhibited by probenecid in isolated myofibres, and by probenecid,
10 µM carbenoxolone or quinine in vivo, suggesting that pannexins play a
more important role in ATP release from adult muscle. ATP release did not
differ between myofibres treated with 10 or 100 µM carbenoxolone,
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confirming that connexins did not contribute to ATP release in adult muscle.
This pattern corresponds to the change in protein expression in muscle cells,
since L6 myoblasts and neonatal muscle strongly express Cx43, but connexin
expression decreases to a low level in adult muscle whereas Panx1 expression
increases. In both L6 myoblasts and in vivo, acidosis-induced ATP release
was inhibited by CFTR inh-172, a specific inhibitor of the cystic fibrosis
transmembrane conductance regulator (CFTR), whereas CFTR activators,
forskolin or apigenin, stimulated ATP release; forskolin or apigenin-stimulated
ATP release from myoblasts was inhibited by 100 µM carbenoxolone,
suggesting that CFTR may play a role in the regulation of connexin opening.
Decreased opening of ATP-releasing channels, resulting in diminished muscle
vasodilation in exercise, may help to explain the decreased exercise tolerance
in patients with CFTR.
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EPIGALLOCATECHIN GALLATE (EGCG) ALLEVIATED
CSM-INDUCED ROS-ACTIVATED INFLAMMATION AND
APOPTOSIS IN AC16 CARDIOMYOCYTES
YM Liang,1 MSM Ip,1,3 JCW Mak1,2,3
Departments of 1Medicine; 2Pharmacology & Pharmacy; 3Research Centre
of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong,
Hong Kong
Objectives: Smoking has been recognized as a major risk factor for
cardiovascular disease (CVD). Cigarette smoke (CS) delivers high
concentration of free radicals to smokers. Reactive oxygen species (ROS)
has been shown to play a critical role in promoting inflammation, inducing
mitochondria damage and inducing apoptosis in the development of CVD.
Thus, we hypothesized that epigallocatechin gallate (EGCG), the major
catechin found in green tea, could attenuate cigarette smoke medium (CSM)induced injury by targeting ROS generation in human AC16 cardiomyocytes
in vitro.
Methods: The AC16 cell line was cultured in DMEM/F12 containing 12.5%
fetal bovine serum, in a CO 2 incubator at 37 oC. CSM was prepared by
bubbling smoke from two cigarettes into 20ml serum-free medium, which
was regarded as 100%. After serum starvation with 1% fetal bovine serum
for 24h, cells were pretreated with EGCG (10 µM), N-acetyl-L-cysteine (NAC,
10 mM), or NF-κB inhibitors SC514 (10 µM) for 30 min before 4% CSM
was added and incubated for an additional 24h. Supernatant was collected for
determination of interleukin (IL)-8 by ELISA. Cells were collected to perform
H2DCF-DA and MitoSox Red assays to determinate cellular ROS and

mitochondrial superoxide by flow cytometry. Apoptotic cells were measured
with Annexin V apoptosis detection kit. Cell lysates were collected for Western
blot analysis.
Results: Exposure of AC16 cells to CSM for 24h markedly induced injuries,
as evidenced by the elevations of cellular ROS and mitochondrial superoxide
production and an increase of IL-8 release in supernatant, as well as increased
apoptotic cells. These injuries were significantly attenuated by the
pretreatment of cells with either EGCG or NAC respectively. Furthermore,
exposure of cells to CSM increased the phosphorylation of NF-κB, which
was abolished in the presence of NF-κB inhibitor SC514, leading to inhibition
of IL-8 release. The increased activation of NF-κB pathway was ameliorated
by pretreatment with either EGCG or NAC, resulting in the reductions of
IL-8 release and apoptotic cells.
Conclusions: EGCG protected against CSM-induced injury by attenuating
oxidative stress, inflammation and apoptosis via inhibiting NF-κB activation
in AC16 cardiomyocytes. These findings suggest EGCG as a promising
cardioprotective agent against ROS-mediated cardiac injury.

CP6.
DEFECTIVE AUTOPHAGY PARTICIPATES IN ENDOTHELIAL
DYSFUNCTION IN DIABETIC MICE
L Zhao, J Liu, L Wang, JY Luo, LS Gou, CW Lau, XY Tian, Y Huang
School of Biomedical Sciences and Institute of Vascular Medicine,
The Chinese University of Hong Kong, Hong Kong
Objectives: Endothelial dysfunction is closely associated with the
development of atherosclerosis and vascular complications in diabetic patients
although the mechanisms underlying endothelial dysfunction are not fully
understood. Recent evidence indicates that autophagic flux is important in
maintaining vascular function. Alterations in autophagic flux have been
implicated in diabetes mellitus and atherosclerosis. However, the role of
autophagy in endothelial cell function is largely unclear. Thus, the present
study aims at examining whether altered autophagy involves diabetic
endothelial dysfunction.
Methods and Results: We detected an increased accumulation of P62 and
LC3 in aortas of diabetic db/db mice compared with non-diabetic db/m+ mice.
Blocking the terminal stage of autophagy with chloroquine increased LC3
and p62 in aortas of db/m+ mice, but not in aortas of db/db mice, indicating
autophagic flux was defective in diabetes. In addition, in cultured human
aortic endothelial cells exposed to oxidized low-density lipoprotein and
advanced glycation end products lead to a similar increased accumulation of
P62 and LC3. Reduced autophagic flux was closely associated with increased
mitochondrial reactive oxygen species production, a marked reduced of
agonist-stimulated endothelial nitric oxide bioavailability and acetylcholineinduced endothelium-dependent relaxations. Furthermore, we identified that
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the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis
and autophagic flux, nuclear localization signal was reduced in db/db mouse
endothelium. Most interestingly, overexpression of TFEB restored autophagic
activity, attenuated mitochondrial ROS production and improved endothelial
function in db/db mice.
Conclusion: The present results suggest that defective autophagy is involved
in endothelial dysfunction in diabetic mice. Restoring autophagic flux reduces
mitochondria ROS and thus improves endothelial function, indicating that
restoration of the impaired autophagy may represent another novel therapeutic
strategy for treating diabetic vascular diseases.
(Supported by CUHK2/CRF/12G, GRF14105814 and CUHK Lui Che Woo
Foundation)
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miR199a-3p REGULATES P53 BY TARGETING CABLES1 IN
MOUSE CARDIAC STEM CELLS TO PROMOTE
PROLIFERATION AND INHIBIT APOPTOSIS THROUGH A
NEGATIVE FEEDBACK LOOP
YS Wang, HJ Ballard
Institute of Cardiovascular Science and Medicine, The University of Hong
Kong, Hong Kong
MicroRNAs (miRNAs) have emerged as crucial factors that regulate
proliferation and apoptosis of cardiac stem cells (CSCs). Although much is
known about their role in maintaining CSCs pluripotency, the mechanisms
by which they affect cell fate decisions that as an essential part in repairment
of heart failure remain poorly understood. Here, we demonstrated a
significantly decreased expression of miR199a-3p in heart failure samples
compared with healthy donors. Meanwhile, we identified miR199a-3p as a
proliferation and apoptosis-associated regulator impacted through Cdk5 and
Abl enzyme substrate 1 (CABLES1) targeting and also attributed to their
repression on P53 protein expression. We further demonstrated that P53
induced miR199a-3p expression, and in turn, miR199-3p decreased P53
activity. Collectively, our findings uncover one new mechanism that P53
induced miR199a-3p expression, and in turn, miR199-3p decreased P53
activity. Therefore, miR199a-3p and P53 are coupled through CABLES1
and comprised a novel negative feedback loop that likely contributes to CSC
proliferation and apoptosis.

CP8.
TETRAMETHYLPYRAZINE PROTECTS AGAINST
H O M O C Y S T E I N E - I N D U C E D B K ca C H A N N E L
DYSFUNCTION VIA INHIBITION OF ER STRESS
WT Sun, XC Wang, SK Mak, J Fu, Q Yang
Division of Cardiology, Department of Medicine and Therapeutics, Institute
of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of
Innovative Medicine, Faculty of Medicine, The Chinese University of Hong
Kong, Hong Kong
Background & Objectives: Large conductance Ca2+-activated K+ (BKCa)
channels in smooth muscle cells play a key role in the regulation of vascular
function. Our latest study showed that endoplasmic reticulum (ER) stress
mediates homocysteine-induced BK Ca channel dysfunction in coronary
arteries. Tetramethylpyrazine (TMP) is a major active ingredient of Ligusticum
chuanxiong (Chuanxiong) that is well known for cardioprotective benefits.
Whether TMP protect vascular cells from ER stress and whether protection
of BKCa channel function is involved however are barely studied. The present
study was designed to investigate the effect of TMP on homocysteine-induced
BKCa channel dysfunction in coronary arteries with understanding the role of
ER stress.
Methods: The vasorelaxant response to BKCa channel activator was examined
by isometric force study in porcine small coronary arteries. Expressions of
ER stress molecules and BKCa channel subunits were evaluated by Western
blot and RT-PCR, and BKCa channel currents were recorded by patch-clamp
in porcine coronary arterial smooth muscle cells (PCASMCs).

J HK Coll Cardiol, Vol 24

Results: TMP preserved the vasodilatory function of BK Ca channels in
coronary arteries subjected to homocysteine exposure. The protective effect
of TMP on BKCa-mediated relaxation was also observed in arteries exposed
to tunicamycin, which is a chemical ER stress inducer. In homocysteineexposed PCASMCs, TMP downregulated the protein expression/
phosphorylation of ER stress molecules, i.e., GRP78, ATF6, p-PERK, p-eIF2α,
and p-IRE1 and meanwhile restored the lowered protein level of BKCa β1.
The restoration of BKCa β1 level by TMP against homocysteine is accompanied
by an enhancement of BKCa channel current.
Conclusions: TMP protects BK Ca channels of coronary arteries from
homocysteine-induced function impairment through inhibition of ER stressmediated loss of channel β1 subunit.
(Supported by RGC/GRF CUHK14118414; Lui Che Woo Institute of
Innovative Medicine - CARE theme 8303303, and CUHK Direct Grant
4054273)
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P01.
A RANDOMIZED CLINICAL TRIAL TO COMPARE THE
EFFECTS OF ICE-WATER IMMERSION WITH COLDWATER IMMERSION ON THE CARDIOVASCULAR
RESPONSES IN FATIGUED RUGBY PLAYERS
SSM Fong,1 GCC Chow,1,2 JWY Chung3
1
School of Public Health, The University of Hong Kong; 2Faculty of Liberal
Arts and Social Sciences, The Education University of Hong Kong;
3
Department of Health and Physical Education, The Education University of
Hong Kong, Hong Kong
Objectives: To compare the effects of ice-water immersion (IWI) with coldwater immersion (CWI) on cardiovascular responses in fatigued rugby players.
Methods: Thirty-one amateur rugby players (mean age ± SD = 21.6±2.9 years
old) were randomly assigned to either the IWI or CWI groups. Participants in
the IWI group (n=13) received intermittent, high-intensity treadmill running
at 90% of maximum heart rate for 3.5 minutes followed by a 1-minute halfbody ice-water immersion (5 oC). Participants in the CWI group (n=18)
underwent the same intervention except that they immersed in cold tap water
instead (25 oC). Measurements were taken at 4 time points: at rest (T1,
baseline), after high-intensity treadmill running and just before IWI/CWI
(T2), right after IWI/CWI (T3), and 30 minutes after IWI/CWI (T4). The
primary outcome measure was systolic (SBP) and diastolic (DBP) blood
pressure as measured by a digital blood pressure monitor. The secondary
outcome measure was heart rate which was monitored continuously using a
Polar heart rate monitor.

Results: Two-way repeated measures analysis of variance results revealed
that both SBP and DBP dropped similarly in the two groups from T2 to T4
though the declines were not significant statistically (p>0.008, Bonferroni
adjusted). As expected, heart rate increased from T1 to T2 (p<0.001), then it
levelled off from T2 to T3 (IWI/CWI period, p>0.008), and it dropped
significantly from T3 to T4 (p<0.001) in both groups. Of note, heart rate
returned to the baseline value within 30 minutes after IWI (p=0.037), but not
after CWI (p<0.001). In addition, no significant group or time-by-group
interaction effects were found for any of the outcome measures.
Conclusions: Post-high-intensity running IWI and CWI elicited similar
cardiovascular responses among amateur rugby players. However, it seems
that IWI is more favorable than CWI as heart rate returned to the baseline
value faster after ice-water immersion. The exact mechanism of this
phenomenon has yet to be explored.

P02.
TRANILAST, ORALLY ACTIVE TRPV2 ANTAGONIST,
AMELIORATES END-STAGE HEART FAILURE IN MICE
WITH DILATED CARDIOMYOPATHY
K Komamura, Y Iwata
Kobe Gakuin University, Japan
Objectives: Expression of transient receptor potential vanilloid 2 (TRPV2),
a calcium-permeable cation channel, increased in the sarcolemma of animal
and human myocardium with DCM. We assessed whether a TRPV2 antagonist,
tranilast, ameliorated heart failure of DCM mice.
Methods: We used 4C30 mice, which has abnormal myocardial calcium
handling, as a model of DCM. Sixteen 4C30 mice of 25 weeks old with endstage heart failure were given no drug (control) or 20 mg/kg/day of carvediol
(group C) or 400 mg/kg/day of tranilast (group T) or both of them (group B)
for 2 weeks.
Results: Blood pressure and heart rate were similar among the 4 groups.
Echocardiography demonstrated tranilast improved fractional shortening
(in %). Control: 6.2±2.5; Group C: 14.2±5.6, NS; Group T: 20.8±3.3,
p<0.01; Group B: 17.2±3.2, p<0.05. Tranilast also improved cardiac
hypertrophy measured with heart-to-body weight ratio (HW/BW in mg/g).
Control: 12.4±2.5; Group C: 11.5±3.4, NS; Group T: 8.6±0.9, p<0.05; Group
B: 5.9±1.1, p<0.01. Sarcolemmal expression of TRPV2 measured with
immunostaing in 4C30 mice increased twice as much as syngeneic C57BL/
6CrSlc. Tranilast, not carvedilol, halved the expression of TRPV2,
corresponding to reduction in [Ca2+]i of isolated cardiomyocytes.
Conclusion: Tranilast improved cardiomyopathy in 4C30 mice, possibly due
to the inhibition of Ca2+ influx through TRPV2.
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P03.
RELATIONS OF POTASSIUM CHANNEL AND CARDIAC
DEPRESSION BY FLUOXETINE
MY Lee
Department of Occupational Therapy, College of Health Science, Honam
University, Republic of Korea
Objectives: Fluoxetine is serotonin-selective reuptake inhibitor (SSRI)
without anticholinergic effects. Although fluoxetine has been used in the
field of anesthetic medicine, the cardiovascular effects of fluoxetine is still
controversial. This study investigated the relation of potassium (K) for
fluoxetine-induced cardiac depression in rat.
Methods: The isolated heart was retrograde-perfused with an oxygenated
modified Krebs-Henseleit buffer. The experimental system was designed to
measure simultaneously left ventricular development pressure (LVDP),
velocity of the change of pressure (dP/dt) and heart rate (HR) of isolated
perfused heart of the perfusate simultaneously. Left ventricular pressure (LVP)
was measured isovolumetrically with a transducer, connected to a thin, waterfilled latex balloon, which was inserted into the left ventricle through the
mitral valve via a left atrial incision.
Results: Fluoxetine produced decreasing of LVDP, dP/dt and HR. And,
Fluoxetine blocked that increasing of LVDP by increasing of potassium.
Especially, the effect of fluoxetine was prolonged after washout.
Conclusions: These results suggest that fluoxetine-induced cardiac depression
can be partly responsible to the block of potassium channel, but these reactions
are prolonged after wash out.

P04.
INFLUENCE OF OBESITY AND OBSTRUCTIVE SLEEP
APNEA SYNDROME ON PLATELET ACTIVITY: ROLE OF
PHOSPHATIDYL INOSITOL 3-KINASE β
Y Liu,1,2 JF Tian,3 R Tian,3 JC Zhang,1,2 DZ Shi,1,2 KJ Chen1,2
1
Centre of Cardiovascular Diseases, Xiyuan Hospital of China Academy of
Chinese Medical Sciences; 2China Heart Institute of Chinese Medicine, China
Academy of Chinese Medical Sciences; 3Beijing Anzhen Hospital, Capital
Medical University, China

(p=0.45). Compared with group C, platelet CD62p, [Ca2+]i and platelet PI3Kβ
expression of group A and B increased significantly (p≤0.05); Compared
with group A, platelet CD62p, [Ca2+]i and platelet PI3Kβ expression of group
B increased significantly (p≤0.05).
Conclusions: In obese patients with OSAS, platelet activation is associated
with greater levels of platelet PI3Kβ expression, and OSAS can increase the
degree of platelet activation of obesity.

Objectives: Platelet function in obstructive sleep apnea syndrome (OSAS)
and obesity has not been clearly elucidated. In this study, we record the
distribution of CD62p and PI3kβ level in human platelets of obese patients
with OSAS, and to analyze the correlation between platelet PI3kβ level and
platelet activation.
Methods: This study included 216 subjects totally, with 70 obese subjects
(Body Mass Index ≥30kg/m2, group A) without OSAS and comorbidities, 91
obese subjects with OSAS (moderate or severe, history of OSAS is more
than 3 years, group B), and 55 healthy participants (group C). The following
morning without breakfast, fresh blood (20 mL) was drawn from an antecubital
vein and collected, and the initial 2 mL of blood was discarded to avoid
spontaneous platelet activation. The fluorescence intensity of CD62p and
cytoplasmic calcium ([Ca 2+]i) in human platelets of patients and healthy
participants were measured with flow cytometry. The PI3kβ level of human
washing platelets among three groups was measured by western blotting.
Results: The groups were matched for age, with a mean age of 38.6±5.1 in
obese subjects with OSAS and 40.2±4.9 in obese subjects without OSAS
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P05.
INHIBITORY EFFECT OF CAVEOLIN-1 ON THE ER
STRESS-INDUCED APOPTOSIS IN MACROPHAGES VIA
VIBRATING THE p38 MAPK PATHWAY
W Yue, ZP Shang
Pathophysiology Department, Taishan Medical College, China
Objectives: To explore the control effects and probable mechanisms of
caveolin-1 on endoplasmic reticulum (ER) stress-induced apoptosis in
RAW264.7 cells.
Methods: RAW264.7 cells were incubated with TG for ER stress-induced
apoptosis model, and then the expression of caveolin-1 was determined by
Western blot. The cells were treated with filipin(III), and then flow cytometry
assay determining the apoptotic rate; laser scanning confocal microscopy
observing the morphological changes of the cells; Western blotting
determining the protein levels of CHOP and p-p38 MAPK.
Results: (1) The expression of caveolin-1 was increased in RAW264.7 cell
treated with thapsingargin; (2) After treatment of filipin(III), the apoptotic
rate was increased; the expression of p-p38 MAPK was reduced; and the
expression of CHOP remain unchanged as compared to TG group.
Conclusion: Caveolin-1 inhibits the process of the TG-induced apoptosis in
RAW264.7 cells through ER stress, one of the mechanisms may being
correlated with promoting the p38 MAPK prosurvival pathway.

P06.
IS ENDOTHELIAL FUNCTION RELATED TO PLASMA
LEVEL OF LIPOCALIN-2 IN MAN?
BMY Cheung,1,3,4,5 Y Wang,2,3,4 KSL Lam,1,3,4 HF Tse1,3,4,5
1
Department of Medicine; 2Department of Pharmacology and Pharmacy;
3
Partner State Key Laboratory of Pharmaceutical Biotechnology; 4Research
Centre of Heart, Brain, Hormone and Healthy Aging; 5 Institute of
Cardiovascular Science and Medicine; The University of Hong Kong, Hong
Kong

Conclusions: Plasma level of lipocalin-2 is unrelated to FMD. Endothelial
function is influenced by many factors, including ageing and diabetes as found
in this study, and also diet and drug therapy. The correlation of lipocalin-2
with creatinine is consistent with it being a marker of renal injury.
(This work was supported by RGC GRF grant HKU 763312.)

Background: Recent animal studies suggested that lipocalin-2 plays a key
role in the development of hypertension, atherosclerosis and endothelial
dysfunction. Lipocalin-2 knockout mice are resistant to the harmful effects
of high fat diet and do not develop hypertension or atherosclerosis. We
therefore hypothesised that lipocalin-2 is also related to endothelial function
in man.
Method: We measured plasma lipocalin-2 concentration in 245 subjects (201
men, 44 women; mean age±SD, 68±9 years old) who had measurements of
brachial artery flow-mediated dilatation (FMD). Among these subjects, 151
had hypertension, 80 had diabetes mellitus and 240 were on lipid lowering
therapy. Brachial artery diameter and flow velocity were measured using a
7.5 MHz ultrasound probe. Scans were taken at baseline, 5 minutes after
tourniquet inflation and after sublingual glyceryl trinitrate spray. The
percentage change in brachial artery diameter following reactive hyperaemia
was calculated. The coefficient of variation of FMD determination was 5%.
Results: Plasma lipocalin-2 correlated with serum creatinine (p=0.23,
p<0.001) but not FMD (p=0.005, p=0.94). FMD correlated inversely with
age (p=-0.14, p=0.03). Diabetes was associated with a lower FMD (p=0.044).

90

October 2016

J HK Coll Cardiol, Vol 24

List of Reviewers 2016
CHAN Jacky
CHAN Ngai Yin
CHEUNG Bernard
CHEUNG Yiu Fai
LAU Suet Ting
YIU Kai Hung

J HK Coll Cardiol, Vol 24

October 2016

91

